Gammaplex 10 % in 200 ML Injection
- RxCUI
- 1876674
- RxNorm name
- Gammaplex 10 % in 200 ML Injection
- Display name
- Gammaplex 10 % in 200 ML Injection
- Full name
- Gammaplex 10 % in 200 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125329 | Gammaplex | Immune Globulin Intravenous (Human) | 351(a) | Disc | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2098af41-aec7-4af7-98bb-54f8ab55f30e | Gammaplex 10 % in 200 ML Injection [PSN] · 200 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex] [SBD] · 200 ML Gammaplex 100 MG/ML Injection [SY] · Gammaplex 10 % per 200 ML Injection [SY] | 4 | 16 | These highlights do not include all the information needed to use GAMMAPLEX ® 10% safely and effectively. See full prescribing information for GAMMAPLEX 10%. GAMMAPLEX 10% Immune Globulin Intravenous [Human], 10% Liquid Initial U.S. Approval: 2017 | 20251023 |